WallStreetZenWallStreetZen

NASDAQ: MNPR
Monopar Therapeutics Stock Ownership - Who owns Monopar Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Monopar Therapeutics insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Chandler RobinsonCEO2026-10-20597$92.59
$55.28kSell
Christopher M. StarrDirector2026-10-018,400$0.01
$42.00Buy
Christopher M. StarrDirector2026-10-01799$79.67
$63.66kSell
Christopher M. StarrDirector2026-10-012,970$78.82
$234.10kSell
Christopher M. StarrDirector2026-10-014,631$78.09
$361.63kSell
Andrew CittadineCOO2026-09-301,944$79.67
$154.88kSell
Quan Anh VuCFO2026-09-30180$79.67
$14.34kSell
Chandler RobinsonCEO2026-09-304,344$79.67
$346.09kSell
Chandler RobinsonCEO2026-09-24600$89.79
$53.87kSell
Chandler RobinsonCEO2026-09-248,368$88.97
$744.50kSell

1 of 6

MNPR insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MNPR insiders and whales buy or sell their stock.

MNPR Shareholders

What type of owners hold Monopar Therapeutics stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Arthur J. Klausner136.69%9,174,944$608.12MInsider
Michael J. 1. Brown71.59%4,805,470$318.51MInsider
Tactic Pharma LLC65.30%4,383,299$290.53MInsider
Chandler Robinson3.42%229,757$15.23MInsider
Andrew Paul Mazar2.81%188,792$12.51MInsider
Christopher M. Starr1.84%123,733$8.20MInsider
Diane Hendricks1.40%93,750$6.21MInsider
Andrew Cittadine0.86%58,054$3.85MInsider
Lavina Talukdar0.21%14,001$927.99kInsider
Kim R. Tsuchimoto0.17%11,486$761.29kInsider

1 of 3

MNPR vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MNPR0.03%99.97%Net SellingNet Selling
EPRX0.04%0.00%
KZIA0.00%0.39%
IBO0.00%2.88%Net SellingNet Selling
PRTA0.09%86.09%Net BuyingNet Buying
View Top Biotech Stocks

Monopar Therapeutics Stock Ownership FAQ

Who owns Monopar Therapeutics?

Monopar Therapeutics (NASDAQ: MNPR) is owned by 0.09% institutional shareholders, 284.53% Monopar Therapeutics insiders, and 0.00% retail investors. Arthur J. Klausner is the largest individual Monopar Therapeutics shareholder, owning 9.17M shares representing 136.69% of the company. Arthur J. Klausner's Monopar Therapeutics shares are currently valued at $608.12M.

If you're new to stock investing, here's how to buy Monopar Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.